Violation Tracker Individual Record
Company:
Rochester Drug Co-Operative, Inc.
Current Parent Company:
Rochester Drug Co-Operative
Penalty:
$20,000,000
Year:
2019
Date:
April 23, 2019
Offense Group:
healthcare-related offenses
Primary Offense:
Controlled Substances Act violation
Secondary Offense:
fraud
Violation Description:
In the first case of felony criminal charges being brought against a corporate drug distributor, Rochester Drug was accused of unlawfully distributing oxycodone and fentanyl, and conspiring to defraud the Drug Enforcement Administration. The company paid a $20 million penalty and entered into a deferred prosecution agreement.
Level of Government:
federal
Action Type:
agency action
Agency:
U.S. Attorney-Southern District of New York
Civil or Criminal Case:
criminal
Prosecution Agreement:
deferred prosecution agreement
HQ Country of Parent:
USA
HQ State of Parent:
New York
Ownership Structure of Parent:
privately held
Major Industry of Parent:
wholesalers
Specific Industry of Parent:
wholesalers-pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
